BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 6, 2010
View Archived Issues
Aldosterone synthase inhibitor LCI-699 shows promise in hypertension trial
Read More
Reduced risk for stroke and embolism with dabigatran compared to warfarin in RE-LY trial
Read More
Unfavorable risk-benefit noted with anticoagulant/antiplatelet therapy in atrial fibrillation
Read More
NeuroSearch claims nicotinic acetylcholine alpha7 receptor ligands and monoamine receptor modulators
Read More
Probiodrug discloses novel glutaminyl cyclase inhibitors
Read More
New SCD-1 inhibitors discovered by sanofi-aventis
Read More
Biolipox presents new leukotriene C4 synthase inhibitors
Read More
Auckland Uniservices discovers novel nitrobenzindole prodrugs for treatment of cancer
Read More
Merck & Co. selects antiobesity CB1 inverse agonist MK-5596 as clinical candidate
Read More
Regadenoson in myocardial perfusion imaging exhibits safety in heart transplant patients
Read More
Pfizer discloses identification of selective PDE9 inhibitors at ACS meeting
Read More
FDA allows GeoVax to start phase I clinical trial of HIV vaccine
Read More
NeurOp and Bristol-Myers Squibb enter drug discovery collaboration
Read More
Stem Cell Therapeutics completes enrollment in phase IIb REGENESIS stroke trial
Read More
QRxPharma begins phase I trial of CR morphine/oxycodone for chronic pain
Read More
ViroPharma begins phase II Cinryze trial in pediatric HAE patients
Read More
VIA Pharmaceuticals reports strategic restructuring and R&D pipeline update
Read More
GSK's Duodart approved for benign prostatic hyperplasia in E.U.
Read More
Ardea reports phase IIb RDEA-594 monotherapy data in hyperuricemia and gout
Read More
Orexigen submits NDA in U.S. for Contrave obesity treatment
Read More
GSK and Isis to develop RNA-targeted therapeutics for rare and infectious diseases
Read More
AMAG and Takeda enter into agreement to develop and market Feraheme
Read More
ArQule reports phase II data on ARQ-197 in non-small cell lung cancer
Read More
Phase II data reported for OMS-103-HP in arthroscopic meniscectomy surgery
Read More
Symphogen begins phase I/II Sym-004 trial in advanced solid tumors
Read More
Alzheimer's Drug Discovery Foundation funds Signum Biosciences' research
Read More